Ken Griffin Sera Prognostics, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 400 shares of SERA stock, worth $3,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$3,496% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding SERA
# of Institutions
73Shares Held
19MCall Options Held
35.4KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$47.5 Million0.43% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$26.5 Million0.27% of portfolio
-
Interwest Venture Management CO2.42MShares$21.1 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$14.4 Million1.44% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$12.3 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $259M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...